Pathology and laboratory medicine are currently experiencing paradigm shifts that are likely to influence how our specialty is practiced in the not-too- distant future. Technical innovations in immunohistochemistry, molecular pathology, and pathology informatics are driving the acquisition of many new and exciting data. That phenomenon may well increase the quality and scope of the diagnostic information being provided by laboratory assays. Simultaneously, however, as new technologies invariably increase the cost of medical testing, considerable pressure has accrued concerning financial con- tainment. Thus far, advocates of “the most, the newest, and the best, regard- less of cost” have largely prevailed. Nonetheless, it is likely that in the near future, there will be considerable movement toward a strict, cost-effective utilization of laboratory resources that is centered on clinical value and direct applicability of test results in regard to individual patient care.
CITATION STYLE
Melanson, S. E. F., Morrison, A. P., Bates, D. W., & Tanasijevic, M. J. (2011). Implementation and Benefits of Computerized Physician Order Entry and Evidence-Based Clinical Decision Support Systems. In Evidence Based Pathology and Laboratory Medicine (pp. 323–335). Springer New York. https://doi.org/10.1007/978-1-4419-1030-1_19
Mendeley helps you to discover research relevant for your work.